Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...
1d
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...
Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially ...
There are around 80 patients who are currently prescribed weight-loss jab Wegovy solely for obesity treatment and the GHA is looking to review guidance for the new highly-effective drug Mounjaro with ...
Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback